Inovio Pharmaceuticals, Inc. (INO)

Publicly reported company facts and saved market data for Inovio Pharmaceuticals, Inc. (INO), with sources and as-of times. Saved data is not a live quote.

Company profile

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools.

Company facts

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $62.0M · as of 2026-10-30
Incorporated in: United States
Company website: www.inovio.com
Exchange: NASDAQ

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price: $2.06
Reported change: +166.91%
Reported volume: 80,500,974
Latest market time: 2026-10-30 20:00 ET

Float and shares outstanding

INO float references and SEC-reported shares outstanding
Measure	Shares	As of	Source and basis
Float F01	81,006,230	2026-05-15	Reported by a single source; not cross-checked.
Historical float F02	74,300,000,000	2025-06-30	Historical estimate from the SEC-disclosed public float value; not current tradable shares.
Shares outstanding (O/S)	103,397,518	2026-08-10	SEC 10-Q filing · filed 2026-08-12

Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.

Short interest

Reported short interest: 21,304,238 shares
Settlement date: 2026-10-15
Source: Market and company data

Exchange-published short interest for the stated settlement date, not a live short position.

Recent daily sessions

The 10 most recent saved daily sessions, through 2026-10-30. Daily OHLC and volume; not real-time.

INO daily open, high, low, close and volume
Date	Open	High	Low	Close	Volume
2026-10-30	0.8637	0.8637	0.5961	0.6024	80,501,400
2026-10-29	0.9401	0.9698	0.6101	0.7718	9,642,419
2026-10-28	0.9298	0.979	0.9108	0.9286	4,569,019
2026-10-27	0.885	0.95	0.8581	0.89	3,798,877
2026-10-26	0.9235	0.94	0.8522	0.8698	2,965,853
2026-10-23	0.8505	0.94	0.8037	0.8971	3,930,158
2026-10-22	0.7999	0.9199	0.7812	0.8389	5,519,408
2026-10-21	1.06	1.09	0.7953	0.7953	11,651,690
2026-10-20	1.01	1.06	0.99	1.01	10,811,450
2026-10-19	1.01	1.02	0.98	1.00	2,124,410

Dilution timeline

As of 2026-10-30T23:50:08.961030+00:00

2026-07-31 · 8-K · Current report filed
2026-07-30 · 424B5 · Prospectus filed
2026-07-29 · 424B5 · Prospectus filed
2026-07-10 · EFFECT · Effectiveness notice filed
2026-07-02 · S-3 · Shelf registration filed
2026-07-02 · S-3 · Shelf registration filed
2026-04-06 · 8-K · Current report filed
2026-04-02 · 424B5 · Prospectus filed
2026-04-02 · 424B5 · Prospectus filed
2026-01-27 · 424B5 · Prospectus filed
2025-11-12 · 424B5 · Prospectus filed
2025-11-12 · 424B5 · Prospectus filed
2025-07-03 · 424B5 · Prospectus filed
2025-07-02 · 424B5 · Prospectus filed

Parsed share counts, prices and warrant terms require Plus or above. Explore plans

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.